Comparison of cost savings (RM) | Cost perspective | Baseline schemea | Alternative Scheme 1b | ||
---|---|---|---|---|---|
Pentaxim® + hepatitis B | Hexaxim® | Pentaxim® + hepatitis B | Hexaxim® | ||
Cost per dose | Direct medical | 31.90 | 17.10 | 31.90 | 17.10 |
Direct non-medical | 54.40 | 27.20 | 54.40 | 27.20 | |
Indirect | 221.33 | 110.66 | 221.33 | 110.66 | |
Societal | 307.63 | 155.00 | 307.63 | 155.00 | |
Cost per FIC | Direct medical | 112.91 | 68.40 | 112.91 | 82.93 |
Direct non-medical | 190.40 | 108.80 | 190.40 | 136.00 | |
Indirect | 774.64 | 442.65 | 774.64 | 553.31 | |
Societal | 1077.95 | 619.90 | 1077.95 | 772.40 | |
Saving | 458.00 | 305.50 | |||
Cost per birth cohort (2019)c | Direct medical | 55,142,582 | 33,402,593 | 55,142,582 | 40,581,220 |
Direct non-medical | 92,980,317 | 53,131,610 | 92,980,317 | 66,414,512 | |
Indirect | 378,288,574 | 171,899,835 | 378,288,574 | 214,874,794 | |
Societal | 526,411,473 | 258,434,038 | 526,411,473 | 321,870,526 | |
Saving | 267,977,435 | 204,540,947 | |||
Cost savings per dose of Hexaxim® | 137.20 | 104.70 |